Exploring the impact of surgical treatment for lung cancer in patients with Airway Obstruction from a Lung Cancer Screening Program
Open Access
- 8 May 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0320704
Abstract
Introduction: Little information is available on the surgical treatment options for patients with Airway Obstruction (AO) and early-stage non-small cell lung cancer (NSCLC) followed in lung cancer screening programs (LCS). This study aims to compare the potential impact of anatomical sub lobar resections vs. lobectomies in these patients. Methods: This is a retrospective analysis of participants who underwent surgical resections within a Lung Cancer Screening Program, including those with AO (post bronchodilator FEV1/FVC < 0.70). The short-term survival, locoregional recurrence, perioperative complications, and difference between pre and postoperative pulmonary function tests were compared between the surgical groups in those with AO. Results: Anatomical sub lobar resections or lobectomies for Stages IA and IB NSCLC were performed in 133 patients. Out of these, 57 had AO. Anatomical sub lobar resections were non-inferior to lobectomies for short-term survival in patients with AO (3-year survival rate: 95.8% vs. 97%, p = 0.83). In these patients, sub lobar resections had a higher recurrence rate (12.5% vs 0%, p < 0.01). No significant differences were found in postoperative complications between surgical techniques (sub lobar 33% vs lobectomy 24%, p = 0.44). Lastly, no significant difference was found on the change between pre and postoperative FEV1 and DLCO (p = 0.96 and 0.79 for FEV1 and DLCO, respectively). Conclusions: The present retrospective analysis suggests that sub lobar resection might be the best surgical option for treating early-stage NSCLC in patients with AO, where lung function preservation techniques are desired, but requires closer follow up to detect recurrence. Further studies in larger samples should confirm our findings.Keywords
This publication has 17 references indexed in Scilit:
- Lung Cancer Screening in People With COPD: The Pamplona-IELCAP ExperienceArchivos de Bronconeumología, 2024
- European Society of Thoracic Surgeons expert consensus recommendations on technical standards of segmentectomy for primary lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2023
- Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive SummaryAmerican Journal of Respiratory and Critical Care Medicine, 2023
- Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trialThe Lancet, 2022
- VATS and Minimally Invasive Resection in Early-Stage NSCLCSeminars in Respiratory and Critical Care Medicine, 2020
- Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)The Lancet Respiratory Medicine, 2018
- Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP)Archivos de Bronconeumología, 2015
- A Decade of Advances in Treatment of Early-Stage Lung CancerClinics in Chest Medicine, 2011
- Assessing the Relationship Between Lung Cancer Risk and Emphysema Detected on Low-Dose CT of the ChestChest, 2007
- Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancerThe Annals of Thoracic Surgery, 1995